Bone-Lift Tablet 0.5mcg

Description

Indications

Bone-Lift Tablet 0.5mcg is primarily indicated in conditions like Neonatal hypocalcemia, Oncogenic hypophosphatemic osteomalacia, Osteomalacia in malabsorption syndrome, Osteoporosis, Parathyroid bone disease, Renal osteodystrophy, Renal tubular osteomalacia, Rickets in premature infants, Sporadic hypophosphatemic osteomalacia, Uremic osteodystrophy, Vitamin D therapy in patients with severe renal impairment, Vitamin D-dependent rickets, Xlinked hypophosphataemic osteomalacia, and can also be given in adjunctive therapy as an alternative drug of choice in Psoriasis.

Contraindication

Bone-Lift Tablet 0.5mcg is contraindicated in conditions like Hypercalcaemia.

Side Effects

The severe or irreversible adverse effects of Bone-Lift Tablet 0.5mcg , which give rise to further complications include Hypercalciuria, Urinary calcium stone formation, Hypercalcemia, CNS depression.Bone-Lift Tablet 0.5mcg produces potentially life-threatening effects which include Coma. which are responsible for the discontinuation of Bone-Lift Tablet 0.5mcg therapy. The signs and symptoms that are produced after the acute overdosage of Bone-Lift Tablet 0.5mcg include Nausea, Vomiting, Diarrhea, Polyuria, Sweating, Headache, Anorexia, Vertigo, Thirst.

 Warnings

Vitamin D should not be administered to patients with hypercalcaemia. Use with extreme caution in children, because they may have increase sensitivity to its effects and should be used with care in patients with renal impairment or calculi or heart disease. Plasma phosphate level should be controlled during vitamin D therapy. Use with caution during pregnancy.